Clinical Trial Update: Study Comparing SUBA™-Itraconazole With SPORANOX® (Itraconazole) in the Treatment of Onychomycosis [Phase 2]

View source ↗

Summary

Phase 2 trial update comparing SUBA-Itraconazole with SPORANOX in onychomycosis has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Onychomycosis

Drugs mentioned

• SPORANOX (Itraconazole)
• SUBA-Itraconazole (itraconazole)

Snippet

Sponsor: Halcygen Pharmaceuticals Limited | Conditions: Onychomycosis | Phase 2 | Status: COMPLETED | Results posted: 2020-08-25